Biomarker Testing and Treatment Patterns Among Patients With PIK3CA Mutation in Advanced Breast Cancer
Clinical trial NCT05982886 · COMPLETED
Trial details
- NCT number
- NCT05982886
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-15
- Primary completion
- 2021-04-01
- Enrollment
- 1093
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.